Pfizer, Teva reach deal to allow launch of generic Viagra by 2017
Pfizer says it reached a settlement with Teva Pharmaceuticals that allows the generic drugmaker to launch a copycat version of its popular erectile dysfunction drug Viagra in 2017.
Pfizer says Teva will pay an undisclosed royalty for a license to produce a generic version of Viagra, one of New York-based Pfizer's bestselling drugs. Viagra generated about $1.14 billion in U.S. sales last year.
Pfizer's patent protecting Viagra from generic competition expires in April 2020, but Teva will be allowed to launch its generic version Dec. 11, 2017.
Pfizer Inc. had sued Teva in 2010 over the Israeli drugmaker's plans to introduce a generic version of Viagra.
The patent protecting another erectile dysfunction drug, Eli Lilly and Co.'s Cialis, also expires in 2017.
Read more Business News
- ATV to 'Slingshot' into productionKelowna - 6:52 pm
- Vernon millionaires can finally sleepVernon / N. Okanagan - 3:01 pm
- Kamloops retiree living a dreamKamloops - 4:29 pm
- Armed robberiesKelowna - 4:38 pm
|QHR Technologies Inc||1.24||+0.05|
|Anavex Life Sciences||0.47||-0.07|
|Copper Mountain Mining||2.03||-0.11|
|Sunrise Resources Ltd||0.035||+0.005|
|Mission Ready Services||0.29||+0.015|
How will you pay for this today? Maybe it’s time to change the way you answer this common checkout question.With more payment options than ever, consumers can find easy ways to save money, simpl...
In the razzle dazzle of Hollywood it is hard to find anyone who stands out from the crowd. The fraternity of Actors, Producers, Directors and various other technical guru’s seem to live in a wo...
This past Sunday I drove from Kelowna to Powell River. For those of you who’ve never had to, particularly in winter, it means rising in the wee hours; managing a treacherous journey on the Coqui...